phase 1_completion
saveLuye Pharma Group Ltd — LY-03021 (Phase I Trial Completion)
community read0 votes
Therapy area: Central Nervous System. Indication: Major Depressive Disorder
Therapy area: Central Nervous System. Indication: Major Depressive Disorder